-
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
Vlaar, A. P. J., de Bruin, S., Busch, M., Timmermans, S. A. M. E. G., van Zeggeren, I. E., Koning, R., ter Horst, L., Bulle, E. B., van Baarle, F. E. H. P., van de Poll, M. C. G., Kemper, E. M., van der Horst, I. C. C., Schultz, M. J., Horn, J., Paulus, F., Bos, L. D., Wiersinga, W. J., Witzenrath, M., Rueckinger, S. & Pilz, K. & 6 others, , Dec 2020, In: The Lancet Rheumatology. 2, 12, p. e764-e773Research output: Contribution to journal › Article* › Academic › peer-review
-
Community-acquired Bacterial Meningitis in Adults With Cerebrospinal Fluid Leakage
ter Horst, L., Brouwer, M. C., van der Ende, A. & van de Beek, D., 1 Jun 2020, In: Clinical infectious diseases. 70, 11, p. 2256-2261 6 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
